These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 16310169)
1. Influence of heparin and dendrimers on the aggregation of two amyloid peptides related to Alzheimer's and prion diseases. Klajnert B; Cortijo-Arellano M; Bryszewska M; Cladera J Biochem Biophys Res Commun; 2006 Jan; 339(2):577-82. PubMed ID: 16310169 [TBL] [Abstract][Full Text] [Related]
2. Influence of phosphorus dendrimers on the aggregation of the prion peptide PrP 185-208. Klajnert B; Cortijo-Arellano M; Cladera J; Majoral JP; Caminade AM; Bryszewska M Biochem Biophys Res Commun; 2007 Dec; 364(1):20-5. PubMed ID: 17927954 [TBL] [Abstract][Full Text] [Related]
3. Molecular interactions of dendrimers with amyloid peptides: pH dependence. Klajnert B; Cladera J; Bryszewska M Biomacromolecules; 2006 Jul; 7(7):2186-91. PubMed ID: 16827586 [TBL] [Abstract][Full Text] [Related]
4. EPR study of the interactions between dendrimers and peptides involved in Alzheimer's and prion diseases. Klajnert B; Cangiotti M; Calici S; Majoral JP; Caminade AM; Cladera J; Bryszewska M; Ottaviani MF Macromol Biosci; 2007 Aug; 7(8):1065-74. PubMed ID: 17654761 [TBL] [Abstract][Full Text] [Related]
5. Amyloidogenic properties of the prion protein fragment PrP(185-208): comparison with Alzheimer's peptide Abeta(1-28), influence of heparin and cell toxicity. Cortijo-Arellano M; Ponce J; Durany N; Cladera J Biochem Biophys Res Commun; 2008 Apr; 368(2):238-42. PubMed ID: 18206983 [TBL] [Abstract][Full Text] [Related]
6. An autocatalytic reaction as a model for the kinetics of the aggregation of beta-amyloid. Sabaté R; Gallardo M; Estelrich J Biopolymers; 2003; 71(2):190-5. PubMed ID: 12767118 [TBL] [Abstract][Full Text] [Related]
7. Cell biology: infectious Alzheimer's disease? Riek R Nature; 2006 Nov; 444(7118):429-31. PubMed ID: 17122841 [No Abstract] [Full Text] [Related]
11. Phosphorus dendrimers affect Alzheimer's (Aβ1-28) peptide and MAP-Tau protein aggregation. Wasiak T; Ionov M; Nieznanski K; Nieznanska H; Klementieva O; Granell M; Cladera J; Majoral JP; Caminade AM; Klajnert B Mol Pharm; 2012 Mar; 9(3):458-69. PubMed ID: 22206488 [TBL] [Abstract][Full Text] [Related]
12. Influence of dendrimer's structure on its activity against amyloid fibril formation. Klajnert B; Cortijo-Arellano M; Cladera J; Bryszewska M Biochem Biophys Res Commun; 2006 Jun; 345(1):21-8. PubMed ID: 16674918 [TBL] [Abstract][Full Text] [Related]
13. Investigation of the mechanism of beta-amyloid fibril formation by kinetic and thermodynamic analyses. Lin MS; Chen LY; Tsai HT; Wang SS; Chang Y; Higuchi A; Chen WY Langmuir; 2008 Jun; 24(11):5802-8. PubMed ID: 18452319 [TBL] [Abstract][Full Text] [Related]
14. Structure and function of amyloid in Alzheimer's disease. Morgan C; Colombres M; Nuñez MT; Inestrosa NC Prog Neurobiol; 2004 Dec; 74(6):323-49. PubMed ID: 15649580 [TBL] [Abstract][Full Text] [Related]
15. Delineating common molecular mechanisms in Alzheimer's and prion diseases. Barnham KJ; Cappai R; Beyreuther K; Masters CL; Hill AF Trends Biochem Sci; 2006 Aug; 31(8):465-72. PubMed ID: 16820299 [TBL] [Abstract][Full Text] [Related]
16. Fitting yeast and mammalian prion aggregation kinetic data with the Finke-Watzky two-step model of nucleation and autocatalytic growth. Watzky MA; Morris AM; Ross ED; Finke RG Biochemistry; 2008 Oct; 47(40):10790-800. PubMed ID: 18785757 [TBL] [Abstract][Full Text] [Related]
17. Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation. Benseny-Cases N; Cócera M; Cladera J Biochem Biophys Res Commun; 2007 Oct; 361(4):916-21. PubMed ID: 17679138 [TBL] [Abstract][Full Text] [Related]
18. Fitting neurological protein aggregation kinetic data via a 2-step, minimal/"Ockham's razor" model: the Finke-Watzky mechanism of nucleation followed by autocatalytic surface growth. Morris AM; Watzky MA; Agar JN; Finke RG Biochemistry; 2008 Feb; 47(8):2413-27. PubMed ID: 18247636 [TBL] [Abstract][Full Text] [Related]
19. High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide. Danielsson J; Pierattelli R; Banci L; Gräslund A FEBS J; 2007 Jan; 274(1):46-59. PubMed ID: 17222176 [TBL] [Abstract][Full Text] [Related]
20. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease. Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]